Anti-inflammatory limonoids from Swietenia macrophylla seeds attenuate IL-1β release via NLRP3 inflammasome inhibition
Phytochemistry · 2027
DOI: 10.1016/j.phytochem.2026.115090 ↗Kurz gefasst
Fachartikel in der Zeitschrift Phytochemistry, 2027. Verfasst von Yun-Peng Sun und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Anhui University of Chinese Medicine, Anhui Province Key Laboratory of Bioactive Natural Products, Hefei, 230012, PR China. Hauptthemen laut MEDLINE: Limonins, NLR Family, Pyrin Domain-Containing 3 Protein, Meliaceae, Seeds. Die Arbeit nennt 33 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Anhui University of Chinese Medicine.
Abstract (Originalsprache)
Seeds of Swietenia macrophylla are recognized as a beneficial dietary supplement due to their pronounced hypoglycemic and hypotensive properties. To explore the pharmaceutical potential of this plant, eight previously undescribed mexicanolide- and phragmalin-type limonoids (1-8), together with twenty known analogues (9-28), were isolated from the seeds. Their planar structures and absolute configurations were elucidated through extensive spectroscopic investigations, electronic circular dichroism (ECD) calculations, and X-ray diffraction analyses. Among them, swimacrolin A (1) was identified as a rare trinor-limonoid possessing a 16,20-dicarboxylic acid mexicanolide skeleton. In an in vitro anti-inflammatory assay, compounds 1-8 did not inhibit nitric oxide (NO) production in lipopolysaccharide (LPS)- stimulated RAW 264.7 macrophages. However, compounds 1-8, 11, 12, 14-18, 20, 21, 23, and 25-28 significantly suppressed interleukin-1β (IL-1β) release in LPS/nigericin (NIG)-induced THP-1 cells, with IC50 values ranging from 0.64 to 23.05 μM. Notably, compound 2 demonstrated marked anti-inflammatory activity (IC50 = 0.64 ± 0.19 μM). Further mechanistic investigation revealed that compound 2 directly binds to the NOD-like receptor family pyrin domain containing 3 (NLRP3) protein, thereby interfering with apoptosis-associated speck-like protein containing a CARD (ASC) oligomerization and inhibiting NLRP3 inflammasome activation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmacy, Anhui University of Chinese Medicine, Anhui Province Key Laboratory of Bioactive Natural Products, Hefei, 230012, PR China.
- School of Pharmacy, Anhui University of Chinese Medicine, Anhui Province Key Laboratory of Bioactive Natural Products, Hefei, 230012, PR China. Electronic address: jinsongliu@ahtcm.edu.cn.
- School of Pharmacy, Anhui University of Chinese Medicine, Anhui Province Key Laboratory of Bioactive Natural Products, Hefei, 230012, PR China. Electronic address: wanggk@ahtcm.edu.cn.
Förderung
- National Natural Science Foundation of China
- Anhui University of Chinese Medicine
Zitieren
APA
Sun, Y. P., Xie, Z., Su, W. B., Zhang, W. L., Yu, Y., Liu, J. S., & Wang, G. K. (2027). Anti-inflammatory limonoids from Swietenia macrophylla seeds attenuate IL-1β release via NLRP3 inflammasome inhibition. Phytochemistry. https://doi.org/10.1016/j.phytochem.2026.115090
Vancouver
Sun YP, Xie Z, Su WB, Zhang WL, Yu Y, Liu JS, et al. Anti-inflammatory limonoids from Swietenia macrophylla seeds attenuate IL-1β release via NLRP3 inflammasome inhibition. Phytochemistry. 2027. doi:10.1016/j.phytochem.2026.115090
BibTeX
@article{Sun2027,
author = {Sun, Yun-Peng and Xie, Zhe and Su, Wan-Bai and Zhang, Wen-Ling and Yu, Yang and Liu, Jin-Song and Wang, Guo-Kai},
title = {Anti-inflammatory limonoids from Swietenia macrophylla seeds attenuate IL-1β release via NLRP3 inflammasome inhibition},
journal = {Phytochemistry},
year = {2027},
doi = {10.1016/j.phytochem.2026.115090}
}
EUVIMED